Basic Materials / Specialty ChemicalsIstanbul
$32.34
+0.38 (+1.19%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 32% · confianza 22%
FCF escenarios
weak_data · normalized FCF $521.4M · quality 48.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
60/100
B
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$14.9B
P/E
1617.0x
↑EV/EBITDA
4.6x
↓ROE
17.5%
↑Gross Margin
41.0%
↑Debt/Equity
0.06
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+36.3%
FCF CAGR
—
FCF margin
10.6%
FCF / Net income
1.00x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $10.70B · net income $1.14B · FCF $1.14B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $10.70B | $10.70B | $9.81B | $6.74B | $4.22B |
| Net Income | $1.14B | $1.14B | $1.22B | $621.4M | $418.7M |
| EBITDA | $2.77B | $2.77B | $2.45B | $1.44B | $640.7M |
| EPS | — | — | 0.03 | 0.01 | 0.04 |
| Gross Margin | 41.0% | 41.0% | 40.3% | 38.6% | 31.1% |
| Operating Margin | 20.3% | 20.3% | 19.6% | 18.1% | 14.3% |
| Net Margin | 10.6% | 10.6% | 12.4% | 9.2% | 9.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.06 | 0.06 | 0.09 | 0.11 | 0.06 |
| Current Ratio | 2.34 | 2.34 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.14B | $1.14B | $521.4M | $205.2M | $-198.5M |
| Returns | |||||
| ROE | 17.5% | 17.5% | 21.4% | 17.9% | 19.2% |
| Valuation | |||||
| P/E | 1617.00 | 1617.00 | 1173.57 | 1405.59 | 322.12 |
| EV/EBITDA | 4.56 | 4.56 | 5.47 | 5.78 | 7.35 |
| P/B | 2.29 | 2.29 | 2.66 | 2.67 | 2.47 |
| Growth & Yield | |||||
| Revenue Growth | 9.1% | 9.1% | 45.5% | 59.7% | — |
| EPS Growth | — | — | 95.8% | -60.7% | — |
| Dividend Yield | 2.0% | 2.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+15.8%
Start / end P/E
n/dx → n/dx
EPS bridge
0.03 → n/d
Residual
+13.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.